Skip to main content

Supplementary Figure S1 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration

Publication ,  Other
Ludwig, AL; McKay, ZP; Carter, GP; Katz, MA; Howell, G; Jain, V; Arvai, S; Dittmer, DP; Bigner, DD; Ashley, DM; Shoaf, ML; Desjardins, A ...
February 3, 2026

<p>Supplementary Figure S1. Extended data on cLN phenotypes after IT PVSRIPO infusion in CT2A mouse glioma.</p>

Duke Scholars

DOI

Publication Date

February 3, 2026
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ludwig, A. L., McKay, Z. P., Carter, G. P., Katz, M. A., Howell, G., Jain, V., … Gromeier, M. (2026). Supplementary Figure S1 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. https://doi.org/10.1158/2326-6066.31239134
Ludwig, Andrea L., Zachary P. McKay, Griffin P. Carter, Mark A. Katz, Georgia Howell, Vaibhav Jain, Stephanie Arvai, et al. “Supplementary Figure S1 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration,” February 3, 2026. https://doi.org/10.1158/2326-6066.31239134.
Ludwig AL, McKay ZP, Carter GP, Katz MA, Howell G, Jain V, Arvai S, Dittmer DP, Bigner DD, Ashley DM, Shoaf ML, Desjardins A, Gregory SG, Brown MC, Gromeier M. Supplementary Figure S1 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. 2026.

DOI

Publication Date

February 3, 2026